PT97061A - Metodo para a utilizacao de tenidap como inibidor da activacao de colagenase e da actividade de mieloperoxidase - Google Patents
Metodo para a utilizacao de tenidap como inibidor da activacao de colagenase e da actividade de mieloperoxidaseInfo
- Publication number
- PT97061A PT97061A PT97061A PT9706191A PT97061A PT 97061 A PT97061 A PT 97061A PT 97061 A PT97061 A PT 97061A PT 9706191 A PT9706191 A PT 9706191A PT 97061 A PT97061 A PT 97061A
- Authority
- PT
- Portugal
- Prior art keywords
- colagenase
- tenidap
- myeloperoxidase
- inhibitor
- activation
- Prior art date
Links
- 102000003896 Myeloperoxidases Human genes 0.000 title 1
- 108090000235 Myeloperoxidases Proteins 0.000 title 1
- 230000004913 activation Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- LXIKEPCNDFVJKC-QXMHVHEDSA-N tenidap Chemical compound C12=CC(Cl)=CC=C2N(C(=O)N)C(=O)\C1=C(/O)C1=CC=CS1 LXIKEPCNDFVJKC-QXMHVHEDSA-N 0.000 title 1
- 229960003676 tenidap Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/495,868 US5008283A (en) | 1990-03-19 | 1990-03-19 | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT97061A true PT97061A (pt) | 1991-10-31 |
| PT97061B PT97061B (pt) | 1998-07-31 |
Family
ID=23970312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97061A PT97061B (pt) | 1990-03-19 | 1991-03-18 | Metodo para a utilizacao de tenidap como inibidor da activacao de colagenase e da actividade de mieloperoxidase |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5008283A (pt) |
| EP (1) | EP0448253A3 (pt) |
| JP (1) | JPH04234815A (pt) |
| KR (1) | KR930010581B1 (pt) |
| AU (2) | AU625409B2 (pt) |
| CA (1) | CA2038409C (pt) |
| HU (1) | HUT60623A (pt) |
| IE (1) | IE910860A1 (pt) |
| IL (1) | IL97521A (pt) |
| MY (1) | MY107235A (pt) |
| NZ (1) | NZ237451A (pt) |
| PT (1) | PT97061B (pt) |
| SG (1) | SG48397A1 (pt) |
| ZA (1) | ZA911979B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
| TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| ES2076106B1 (es) * | 1993-08-26 | 1996-06-16 | Pfizer | Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas |
| US5795902A (en) * | 1993-09-02 | 1998-08-18 | Pfizer Inc. | 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions |
| US5516699A (en) * | 1994-02-16 | 1996-05-14 | Institute Of Molecular Biology, Inc. | Pyridinoline crosslinks as markers of periodontal and peri-implant disease activity |
| US5545656A (en) * | 1995-04-05 | 1996-08-13 | Pfizer Inc. | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease |
| US5827840A (en) * | 1996-08-01 | 1998-10-27 | The Research Foundation Of State University Of New York | Promotion of wound healing by chemically-modified tetracyclines |
| AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
| US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
| PT2026651E (pt) | 2006-03-08 | 2013-06-04 | Cortria Corp | Terapia combinada com inibidores cox não selectivos para prevenir lesões gástricas relacionadas com a cox |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4678802A (en) * | 1985-07-09 | 1987-07-07 | Pfizer Inc. | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
| RO105052B1 (en) * | 1987-02-02 | 1994-12-01 | Pfizer | Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide |
| DE3852145T2 (de) * | 1987-02-18 | 1995-04-06 | Beecham Group Plc | Indolderivate, Verfahren zu deren Herstellung und pharmazeutische Präparate, die diese enthalten. |
| US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| DE3814504A1 (de) * | 1988-04-29 | 1989-11-09 | Bayer Ag | (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5006547A (en) * | 1990-03-19 | 1991-04-09 | Pfizer Inc. | Tenidap as an inhibitor of the release of elastase by neutrophils |
-
1990
- 1990-03-19 US US07/495,868 patent/US5008283A/en not_active Expired - Lifetime
-
1991
- 1991-03-07 EP EP19910301890 patent/EP0448253A3/en not_active Withdrawn
- 1991-03-07 SG SG1996009351A patent/SG48397A1/en unknown
- 1991-03-12 IL IL9752191A patent/IL97521A/en not_active IP Right Cessation
- 1991-03-15 IE IE086091A patent/IE910860A1/en unknown
- 1991-03-15 NZ NZ237451A patent/NZ237451A/en unknown
- 1991-03-15 CA CA002038409A patent/CA2038409C/en not_active Expired - Fee Related
- 1991-03-18 PT PT97061A patent/PT97061B/pt not_active IP Right Cessation
- 1991-03-18 HU HU91872A patent/HUT60623A/hu unknown
- 1991-03-18 AU AU73587/91A patent/AU625409B2/en not_active Ceased
- 1991-03-18 ZA ZA911979A patent/ZA911979B/xx unknown
- 1991-03-18 KR KR1019910004236A patent/KR930010581B1/ko not_active Expired - Fee Related
- 1991-03-18 MY MYPI91000438A patent/MY107235A/en unknown
- 1991-03-19 JP JP3130750A patent/JPH04234815A/ja active Pending
-
1992
- 1992-07-09 AU AU19574/92A patent/AU637745B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HU910872D0 (en) | 1991-09-30 |
| AU625409B2 (en) | 1992-07-09 |
| IL97521A0 (en) | 1992-06-21 |
| KR930010581B1 (ko) | 1993-10-30 |
| ZA911979B (en) | 1992-10-28 |
| PT97061B (pt) | 1998-07-31 |
| EP0448253A2 (en) | 1991-09-25 |
| EP0448253A3 (en) | 1992-04-01 |
| AU7358791A (en) | 1991-12-12 |
| JPH04234815A (ja) | 1992-08-24 |
| AU1957492A (en) | 1992-09-10 |
| IL97521A (en) | 1995-12-31 |
| US5008283A (en) | 1991-04-16 |
| IE910860A1 (en) | 1991-09-25 |
| CA2038409C (en) | 1995-01-24 |
| AU637745B2 (en) | 1993-06-03 |
| HUT60623A (en) | 1992-10-28 |
| NZ237451A (en) | 1997-02-24 |
| KR910016326A (ko) | 1991-11-05 |
| SG48397A1 (en) | 1998-04-17 |
| MY107235A (en) | 1995-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR8904593A (pt) | Estrutura absorvente unificada,dispositivo adequado para incontinencia,tampao e revestimento de ferimento | |
| HUT77662A (hu) | Kezelt fedőlappal ellátott pelenka | |
| FI952703L (fi) | Suuren aktiivisuuden etyleenisilektiiviset metalloseenit | |
| FI961158L (fi) | Puheaktiivisuuden ilmaisin | |
| ATA903993A (de) | Pth-analoga | |
| FI956338A0 (fi) | Absorboivia tuotteita | |
| DE69330076D1 (de) | Absorbierender Gegenstand | |
| DE69332034D1 (de) | Absorbierender Gegenstand | |
| FI943528A7 (fi) | Absorbenttituotteita | |
| DE68929358D1 (de) | Absorbierender Gegenstand | |
| BR9500820A (pt) | Artigo absorvente | |
| BR9510278A (pt) | Artigo absorvente | |
| BR9510120A (pt) | Artigo absorvente | |
| BR9508299A (pt) | Artigo absorvente | |
| MX9205113A (es) | Agentes de recubrimiento acuosos y procedimiento para su obtencion | |
| DK0625895T3 (da) | Absorptionslegeme til en absorberende artikel | |
| DE69514816D1 (de) | Absorbierender artikel | |
| NO890503L (no) | Vandig blekemiddel. | |
| PT97061A (pt) | Metodo para a utilizacao de tenidap como inibidor da activacao de colagenase e da actividade de mieloperoxidase | |
| DE69522771D1 (de) | Absorbierender artikel | |
| BR9508567A (pt) | Artigo absorvente | |
| NO901265D0 (no) | Gass- og luktabsorberende anordning. | |
| FI943871A0 (fi) | Pidätyskyvyttömyyssuoja | |
| BR9510116A (pt) | Artigo absorvente | |
| KR960702291A (ko) | 흡수성 물품 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19910710 |
|
| FG3A | Patent granted, date of granting |
Effective date: 19980415 |
|
| MM3A | Annulment or lapse |
Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19991031 |